The company's CEO points to using a subscription-based model, being a platform that allows for technology integration and scale and transparency.

These tools, available through the myCigna member portal, are designed to make navigating health insurance more ...

Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell ...

According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

The booking feature is now live for all Blue Shield employer-sponsored plans, Individual and Family Plans and Medicare ...

The United States has twice the postpartum hemorrhage mortality rate of other developed countries, which is why it’s ...

A cloud-based digital twin simulation, coupled with automated insulin delivery, allows patients with diabetes to experiment ...

Investigators found that making a few changes to a common patient-reported outcomes assessment improved its validity in patients with Duchenne muscular dystrophy.

Findings mark the first time a neoadjuvant immunotherapy regimen has demonstrated a significant survival benefit in a ...

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.